Mineralys Therapeutics
MLYS
$13.00
Share price
-1.14%
Change (1 day)
-18.85%
Change (1 year)
Categories
Mineralys Therapeutics (MLYS) - P/B ratio
P/B ratio as of May 2024 : 2.71
According to Mineralys Therapeutics's latest financial reports the company has a price-to-book ratio of 2.71.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Mineralys Therapeutics - P/B ratio (from 2023 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.47 | |
| 2022-12-31 | N/A | |
| 2021-12-31 | N/A |